Community support continues to rally around Chris Sluman, a North Bay resident recently diagnosed with an aggressive form of leukemia, with fundraising efforts nearing , totaling over $115,000.
Sluman, 33, received a diagnosis of B-cell acute lymphoblastic leukemia on . The diagnosis sparked an immediate outpouring of support, initially through a GoFundMe campaign launched by colleagues of his wife, Hailey Bertrand-Sluman, at Parkside Animal Hospital, where she works as a veterinarian. The funds are intended to cover treatment costs not fully reimbursed by the Ontario Health Insurance Plan (OHIP).
Currently undergoing intensive chemotherapy in Sudbury, Sluman faces a complex treatment pathway. His wife shared an update earlier this week, expressing gratitude for the sustained support. “Though it won’t stop me from trying, the continued outpouring of love and help even a month after diagnosis is absolutely astounding,” she wrote. “You all have helped us feel so very cared for.”
The financial burden associated with Sluman’s care is substantial. While initial estimates were lower, the cost of potentially life-saving medications – Blinatumomab (Blina) and Ponatinib – is significant. These drugs, approved by Health Canada, are not covered by the Ontario Drug Benefit (ODB) program. The estimated cost for a five-round course of Blina alone is $575,000, with an additional $75,000 anticipated for Ponatinib.
Bertrand-Sluman has described the physical toll the aggressive chemotherapy is taking on her husband. His white blood cell count remains suppressed, a common side effect of the treatment, though doctors have assured the family What we have is a normal and, in fact, preferable outcome. He experiences significant fatigue, requiring much of his day to be spent resting, and finds even simple tasks like showering and eating exhausting. Notably, he has not experienced nausea or pain.
The family recently returned to North Bay for a week while awaiting the next phase of Sluman’s treatment. During this time, due to his immunocompromised state, he is unable to receive visitors. Bertrand-Sluman also indicated they are actively seeking assistance from pharmaceutical companies to help offset the medication costs. A recent development offers some relief, with a 30% discount on Ponatinib, reducing the daily cost from $330 to $253.
Amidst the medical challenges, the family finds strength in moments with their daughter, Briar. “We live for Briar’s visits and the artwork, snuggles, and entertainment,” Bertrand-Sluman shared.
The North Bay community is organizing several fundraising events to support the Sluman family. On , a “Night of Community and Support” dinner and silent auction will be held at Churchill’s Prime Rib House. Organized by Steve and Mark Deacon of Deacon Wealth Management, all proceeds from the $250-per-plate tickets will go directly to the family, as the business is covering the cost of the meal. Interested individuals can secure tickets by emailing [email protected] or texting (416) 805-7482. Space is limited to 100 seats.
Another event, “Stand With Sluman,” is scheduled for , at Gateway City Brewery. This event will feature live music, trivia, and a silent auction, with a $20 entry fee, all benefiting the Sluman family.
Donations continue to be accepted through the GoFundMe campaign, which can be found here. These funds will help cover treatment expenses, travel costs, and lost income during Sluman’s ongoing care.
Acute lymphoblastic leukemia (ALL) is a type of cancer of the blood and bone marrow that affects white blood cells. While treatment advances have significantly improved outcomes for many patients with ALL, the financial burden associated with specialized therapies can be substantial, highlighting the importance of community support in navigating these challenging circumstances.
